The Kaplan-Meier plotter was used to investigate the expression of ERK1 (MAPK3) and ERK2 (MAPK1) across breast cancer samples from all breast cancer patients (not stratified by disease subtype). This evidence concerns the gene MAPK1 and breast cancer.